Tech Company Financing Transactions

Azelon Pharmaceuticals Funding Round

Azelon Pharmaceuticals closed a $42.5 million Series B funding round on 5/18/2005. Investors included Alta Partners, Frazier Healthcare Partners and Prospect Venture Partners.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

200 Barr Harbor Dr. 400
West Conshohocken, PA 19428
USA

Phone

(610) 260-6045

Website

www.azelon.com

Email Address

[email protected]

Overview

The lead program for the Company, a next-generation PTH analogue (Ostabolin-C(TM) s.c. injection) for the treatment of osteoporosis, recently began a Phase II clinical trial. Approximately 250 patients will receive daily injections of one of four doses of Ostabolin-C(TM) or placebo for four months in 25 centers located in the US and Canada.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Joan Lau

        

Browse more venture capital transactions:

Prev: 5/18/2005: Netuitive venture capital transaction
Next: 5/18/2005: Wright Medical venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary